vs
Progyny, Inc.（PGNY）とPennant Group, Inc.（PNTG）の財務データ比較。上の社名をクリックして会社を切り替えられます
Progyny, Inc.の直近四半期売上が大きい（$318.4M vs $289.3M、Pennant Group, Inc.の約1.1倍）。Progyny, Inc.の純利益率が高く（3.9% vs 3.0%、差は0.9%）。Pennant Group, Inc.の前年同期比売上増加率が高い（53.2% vs 6.7%）。Progyny, Inc.の直近四半期フリーキャッシュフローが多い（$48.6M vs $17.4M）。過去8四半期でPennant Group, Inc.の売上複合成長率が高い（35.8% vs 7.0%）
Progyny, Inc.は米国を中心に事業を展開する有力な不妊治療・家族形成支援福利厚生サービスプロバイダーです。企業顧客と提携し、体外受精、妊孕性温存、養子縁組支援、代理出産サポートなどの福利厚生を提供し、多様な業種の従業員にサービスを届けています。
ペナントグループ株式会社は米国に本社を置く医療サービス事業者で、在宅医療、ホスピスケア、高齢者向け居住ソリューション、熟練看護支援を提供しています。米国の数十州で事業を展開し、主に高齢者や医療的ケアを必要とする弱者層を対象としてサービスを提供しています。
PGNY vs PNTG — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $318.4M | $289.3M |
| 純利益 | $12.5M | $8.6M |
| 粗利率 | 24.1% | — |
| 営業利益率 | 4.8% | 6.0% |
| 純利益率 | 3.9% | 3.0% |
| 売上前年比 | 6.7% | 53.2% |
| 純利益前年比 | 18.5% | 50.0% |
| EPS（希薄化後） | $0.14 | $0.25 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $318.4M | $289.3M | ||
| Q3 25 | $313.3M | $229.0M | ||
| Q2 25 | $332.9M | $219.5M | ||
| Q1 25 | $324.0M | $209.8M | ||
| Q4 24 | $298.4M | $188.9M | ||
| Q3 24 | $286.6M | $180.7M | ||
| Q2 24 | $304.1M | $168.7M | ||
| Q1 24 | $278.1M | $156.9M |
| Q4 25 | $12.5M | $8.6M | ||
| Q3 25 | $13.9M | $6.1M | ||
| Q2 25 | $17.1M | $7.1M | ||
| Q1 25 | $15.1M | $7.8M | ||
| Q4 24 | $10.5M | $5.8M | ||
| Q3 24 | $10.4M | $6.2M | ||
| Q2 24 | $16.5M | $5.7M | ||
| Q1 24 | $16.9M | $4.9M |
| Q4 25 | 24.1% | — | ||
| Q3 25 | 23.2% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 21.3% | — | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 22.4% | — |
| Q4 25 | 4.8% | 6.0% | ||
| Q3 25 | 6.9% | 4.5% | ||
| Q2 25 | 7.3% | 5.3% | ||
| Q1 25 | 7.5% | 6.0% | ||
| Q4 24 | 5.3% | 4.9% | ||
| Q3 24 | 4.3% | 6.0% | ||
| Q2 24 | 6.8% | 5.7% | ||
| Q1 24 | 6.7% | 5.4% |
| Q4 25 | 3.9% | 3.0% | ||
| Q3 25 | 4.4% | 2.7% | ||
| Q2 25 | 5.1% | 3.2% | ||
| Q1 25 | 4.6% | 3.7% | ||
| Q4 24 | 3.5% | 3.0% | ||
| Q3 24 | 3.6% | 3.4% | ||
| Q2 24 | 5.4% | 3.4% | ||
| Q1 24 | 6.1% | 3.1% |
| Q4 25 | $0.14 | $0.25 | ||
| Q3 25 | $0.15 | $0.17 | ||
| Q2 25 | $0.19 | $0.20 | ||
| Q1 25 | $0.17 | $0.22 | ||
| Q4 24 | $0.12 | $0.16 | ||
| Q3 24 | $0.11 | $0.20 | ||
| Q2 24 | $0.17 | $0.18 | ||
| Q1 24 | $0.17 | $0.16 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $112.2M | — |
| 総負債低いほど良い | — | $168.8M |
| 株主資本純資産 | $516.0M | $374.3M |
| 総資産 | $742.4M | $968.2M |
| 負債/資本比率低いほどレバレッジが低い | — | 0.45× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $112.2M | — | ||
| Q3 25 | $134.0M | — | ||
| Q2 25 | $132.5M | — | ||
| Q1 25 | $109.2M | — | ||
| Q4 24 | $162.3M | — | ||
| Q3 24 | $91.5M | — | ||
| Q2 24 | $95.0M | — | ||
| Q1 24 | $115.0M | — |
| Q4 25 | — | $168.8M | ||
| Q3 25 | — | $26.0M | ||
| Q2 25 | — | $37.0M | ||
| Q1 25 | — | $52.5M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $108.9M | ||
| Q2 24 | — | $82.2M | ||
| Q1 24 | — | $83.3M |
| Q4 25 | $516.0M | $374.3M | ||
| Q3 25 | $560.0M | $343.0M | ||
| Q2 25 | $515.0M | $333.6M | ||
| Q1 25 | $467.2M | $323.0M | ||
| Q4 24 | $422.1M | $312.0M | ||
| Q3 24 | $434.9M | $187.3M | ||
| Q2 24 | $456.2M | $173.0M | ||
| Q1 24 | $571.6M | $164.2M |
| Q4 25 | $742.4M | $968.2M | ||
| Q3 25 | $795.2M | $753.6M | ||
| Q2 25 | $761.0M | $751.4M | ||
| Q1 25 | $730.3M | $743.6M | ||
| Q4 24 | $607.1M | $679.5M | ||
| Q3 24 | $660.0M | $646.8M | ||
| Q2 24 | $698.6M | $602.5M | ||
| Q1 24 | $794.3M | $578.2M |
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.48× | ||
| Q1 24 | — | 0.51× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $54.2M | $21.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $48.6M | $17.4M |
| FCFマージンFCF / 売上 | 15.3% | 6.0% |
| 設備投資強度設備投資 / 売上 | 1.8% | 1.2% |
| キャッシュ転換率営業CF / 純利益 | 4.34× | 2.43× |
| 直近12ヶ月FCF直近4四半期 | $191.8M | $36.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $54.2M | $21.0M | ||
| Q3 25 | $50.7M | $13.9M | ||
| Q2 25 | $55.5M | $34.6M | ||
| Q1 25 | $49.8M | $-21.2M | ||
| Q4 24 | $52.2M | $20.6M | ||
| Q3 24 | $44.5M | $7.7M | ||
| Q2 24 | $56.7M | $10.5M | ||
| Q1 24 | $25.7M | $545.0K |
| Q4 25 | $48.6M | $17.4M | ||
| Q3 25 | $46.0M | $10.5M | ||
| Q2 25 | $50.2M | $31.6M | ||
| Q1 25 | $47.0M | $-23.2M | ||
| Q4 24 | $50.3M | $17.2M | ||
| Q3 24 | $42.7M | $6.8M | ||
| Q2 24 | $55.8M | $8.9M | ||
| Q1 24 | $24.9M | $-2.6M |
| Q4 25 | 15.3% | 6.0% | ||
| Q3 25 | 14.7% | 4.6% | ||
| Q2 25 | 15.1% | 14.4% | ||
| Q1 25 | 14.5% | -11.1% | ||
| Q4 24 | 16.8% | 9.1% | ||
| Q3 24 | 14.9% | 3.8% | ||
| Q2 24 | 18.4% | 5.3% | ||
| Q1 24 | 8.9% | -1.7% |
| Q4 25 | 1.8% | 1.2% | ||
| Q3 25 | 1.5% | 1.5% | ||
| Q2 25 | 1.6% | 1.4% | ||
| Q1 25 | 0.9% | 0.9% | ||
| Q4 24 | 0.6% | 1.8% | ||
| Q3 24 | 0.6% | 0.5% | ||
| Q2 24 | 0.3% | 1.0% | ||
| Q1 24 | 0.3% | 2.0% |
| Q4 25 | 4.34× | 2.43× | ||
| Q3 25 | 3.65× | 2.29× | ||
| Q2 25 | 3.24× | 4.89× | ||
| Q1 25 | 3.31× | -2.73× | ||
| Q4 24 | 4.95× | 3.57× | ||
| Q3 24 | 4.27× | 1.24× | ||
| Q2 24 | 3.44× | 1.84× | ||
| Q1 24 | 1.52× | 0.11× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |
